Evidence map›Paper›PMID 37454260›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2023

Efficacy of Lushi Runzao decoction on ameliorating Sjogren's syndrome: a network pharmacology and experimental verification-based study.

Pang Fengtao, L I Kesong, Zhang Yi, Tang Xiaopo, Zhou Xinyao

Abstract read
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Network pharmacology approach to unveiling the mechanism of berberine in the amelioration of morphine tolerance.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pang FengtaoDepartment of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100053, China.
L I KesongDepartment of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100053, China.
Zhang YiDepartment of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100053, China.
Tang XiaopoDepartment of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100053, China.
Zhou XinyaoDepartment of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100053, China.

Funding

National Natural Science Foundation of China: Based on the Intestinal flora/SCFAs/FFA2 Approach to Explore the Mechanism of Lushi Runzao Decoction in Regulating Th17/Treg Immune Balance to treat Sjogren's Syndrome 82104837
6 · The paper itself

Abstract

objectiveTo investigate the possible mechanism underlying the effect of the Lushi Runzao decoction on Sjogren's syndrome using network pharmacology and to verify the mechanismsanimal experiments.

methodsAvailable biological data on each drug in the Lushi Runzao decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and the target proteins of Sjogren's syndrome were retrieved from the GeneCards database. Information regarding Sjogren's syndrome and the targets of the drugs were compared to obtain overlapping elements. This information was imported into the STRING platform to obtain a protein-protein interaction network diagram, following which a "component-target" network diagram was constructed using screened drug components and target informationCytoscape software. The database for annotation, visualization, and integrated discovery was used for Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathways analyses. Pathway information predicted by network pharmacology was verified using animal experiments.

resultsThe Lushi Runzao decoction ameliorated Sjogren's syndrome mainly by influencing tumor necrosis factor as well as certain cytokines and chemokines. The decoction also influenced the interleukin-17 and advanced glycosylation end products (AGE)-receptor for AGE signaling pathways.

conclusionThe Lushi Runzao decoction ameliorates Sjogren's syndromemultiple targets and multiple signaling pathways. Network pharmacology is useful for making a comprehensive prediction regarding the efficacy of the Lushi Runzao decoction, and this information may be helpful in clinical research.

Indexed as

Drugs, Chinese HerbalSjogren's SyndromeAnimalsCytokinesDatabases, FactualGlycation End Products, AdvancedMedicine, Chinese TraditionalNetwork PharmacologyCytokinesDrugs, Chinese HerbalGlycation End Products, Advancedexperimental verificationimmune system diseasesLushi Runzao decoctionnetwork pharmacologytumor necrosis factors

Identifiers

PMID37454260
PMCPMC10320455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.